Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yanxu Li, Hao Zou, Zekun Zheng, Zhuoheng Liu, Huiyuan Hu, Wei Wu & Tao Wang. (2023) Advances in the Study of Bioactive Nanoparticles for the Treatment of HCC and Its Postoperative Residual Cancer. International Journal of Nanomedicine 18, pages 2721-2735.
Read now
Read now
Jinying Wei, Guangping Meng, Jing Wu, Ying Wang, Qiang Zhang, Ting Dong, Jin Bao, Chunyan Wang & Jie Zhang. (2022) MicroRNA-326 impairs chemotherapy resistance in non small cell lung cancer by suppressing histone deacetylase SIRT1-mediated HIF1α and elevating VEGFA. Bioengineered 13:3, pages 5685-5699.
Read now
Read now
Liqiang Qi, Bo Sun, Beibei Yang & Su Lu. (2021) circHIPK3 (hsa_circ_0000284) Promotes Proliferation, Migration and Invasion of Breast Cancer Cells via miR-326. OncoTargets and Therapy 14, pages 3671-3685.
Read now
Read now
Articles from other publishers (17)
Meiling Zhou, Liang Xiao, Jing Jin, Yin Wang, Peiyu Guo, Jinhua Luo, Magdalena Skonieczna & Ruixue Huang. (2023) Role of p53/circRNA0085439/Ku70 axis in DNA damage response in lung cells exposed to ZnO nanoparticles: Involvement of epigenetic regulation. Cancer Nanotechnology 14:1.
Crossref
Crossref
Mario Romeo, Marcello Dallio, Flavia Scognamiglio, Lorenzo Ventriglia, Marina Cipullo, Annachiara Coppola, Chiara Tammaro, Giuseppe Scafuro, Patrizia Iodice & Alessandro Federico. (2023) Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. Cancers 15:21, pages 5178.
Crossref
Crossref
Leonard Kaps, María José Limeres, Paul Schneider, Malin Svensson, Yanira Zeyn, Silvia Fraude, Maximiliano L. Cacicedo, Peter R. Galle, Stephan Gehring & Matthias Bros. (2023) Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications. International Journal of Molecular Sciences 24:14, pages 11869.
Crossref
Crossref
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Konstantinos Papanikolopoulos, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Dimitris Matthaios & Michalis V. Karamouzis. (2023) An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches. International Journal of Molecular Sciences 24:8, pages 7168.
Crossref
Crossref
Anas Ahmad, Summya Rashid, Anis Ahmad Chaudhary, Abdullah S. Alawam, Mohammad Ibrahim Alghonaim, Syed Shadab Raza & Rehan Khan. (2023) Nanomedicine as potential cancer therapy via targeting dysregulated transcription factors. Seminars in Cancer Biology 89, pages 38-60.
Crossref
Crossref
Alexander A. Guda, Mikhail V. Kirichkov, Viktor V. Shapovalov, Alexey I. Muravlev, Danil M. Pashkov, Sergey A. Guda, Anton P. Bagliy, Sergey A. Soldatov, Sergey V. Chapek & Alexander V. Soldatov. (2023) Machine Learning Analysis of Reaction Parameters in UV-Mediated Synthesis of Gold Nanoparticles. The Journal of Physical Chemistry C 127:2, pages 1097-1108.
Crossref
Crossref
Tao Jiang, Shenghong Miao, Jingjie Shen, Wenjing Song, Shenglong Tan & Dandan Ma. (2023) Enhanced effects of antagomiR-3074-3p-conjugated PEI-AuNPs on the odontogenic differentiation by targeting FKBP9. Journal of Tissue Engineering 14.
Crossref
Crossref
Senyo S. Whyte, Rebekah Karns, Kyung‐Won Min, Jung‐Hyun Cho, Sanghoon Lee, Charissa Lake, Alexander Bondoc, Je‐Hyun Yoon & Soona Shin. (2022)
Integrated analysis using
ToppMiR
uncovers altered
miRNA– mRNA
regulatory networks in pediatric hepatocellular carcinoma—A pilot study
. Cancer Reports 6:1.
Crossref
Crossref
Meabh Doherty, Tongchuan Wang, Dimitrios A. Lamprou & Jonathan A Coulter. (2022) Microfluidic technologies in tumour metabolism. International Journal of Pharmaceutics 629, pages 122370.
Crossref
Crossref
Diana P. Sousa & João Conde. (2022) Gold Nanoconjugates for miRNA Modulation in Cancer Therapy: From miRNA Silencing to miRNA Mimics. ACS Materials Au 2:6, pages 626-640.
Crossref
Crossref
WeiLu Jia, YingHui Han, XinYu Mao, WenJing Xu & YeWei Zhang. (2022) Nanotechnology strategies for hepatocellular carcinoma diagnosis and treatment. RSC Advances 12:48, pages 31068-31082.
Crossref
Crossref
Samar Samir Youssef, Asmaa El fiky, Mohamed M Nabeel, Hend Ibrahim Shousha, Tamer Elbaz, Dalia Omran, Mohammad Saeed Marie, Mohammad A Elzahry, Amr Abul-Fotouh, Ahmed Hashem, Mohamed F Guda & Ashraf O Abdelaziz. (2022) Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians. World Journal of Hepatology 14:8, pages 1562-1575.
Crossref
Crossref
Bornika Roy, Sampa Ghose & Subhrajit Biswas. (2022) Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma. Seminars in Cell & Developmental Biology 124, pages 134-144.
Crossref
Crossref
Xin-Yu Liu, Jing-Quan Wang, Charles R. AshbyJrJr, Leli Zeng, Ying-Fang Fan & Zhe-Sheng Chen. (2021) Gold nanoparticles: synthesis, physiochemical properties and therapeutic applications in cancer. Drug Discovery Today 26:5, pages 1284-1292.
Crossref
Crossref
Soudeh Ghafouri-Fard, Kasra Honarmand Tamizkar, Bashdar Mahmud Hussen & Mohammad Taheri. (2021) MicroRNA signature in liver cancer. Pathology - Research and Practice 219, pages 153369.
Crossref
Crossref
David Vetvicka, Ladislav Sivak, Chinmay M. Jogdeo, Raj Kumar, Rubayat Khan, Yu Hang & David Oupický. (2021) Gene silencing delivery systems for the treatment of pancreatic cancer: Where and what to target next?. Journal of Controlled Release 331, pages 246-259.
Crossref
Crossref
Zhen-zi Bai, Hong-yan Li, Cheng-hua Li, Chuan-lun Sheng & Xiao-nan Zhao. (2020) RETRACTED ARTICLE: M1 Macrophage-Derived Exosomal MicroRNA-326 Suppresses Hepatocellular Carcinoma Cell Progression Via Mediating NF-κB Signaling Pathway. Nanoscale Research Letters 15:1.
Crossref
Crossref